CA2407603C - Porphyromonas gingivalis recombinant proteins and truncations - Google Patents

Porphyromonas gingivalis recombinant proteins and truncations Download PDF

Info

Publication number
CA2407603C
CA2407603C CA2407603A CA2407603A CA2407603C CA 2407603 C CA2407603 C CA 2407603C CA 2407603 A CA2407603 A CA 2407603A CA 2407603 A CA2407603 A CA 2407603A CA 2407603 C CA2407603 C CA 2407603C
Authority
CA
Canada
Prior art keywords
seq
residues
polypeptide
gingivalis
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2407603A
Other languages
English (en)
French (fr)
Other versions
CA2407603A1 (en
Inventor
Ian George Barr
Larissa Czajkowski
Bruce Carter Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
University of Melbourne
Original Assignee
CSL Ltd
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd, University of Melbourne filed Critical CSL Ltd
Priority to CA2750984A priority Critical patent/CA2750984A1/en
Publication of CA2407603A1 publication Critical patent/CA2407603A1/en
Application granted granted Critical
Publication of CA2407603C publication Critical patent/CA2407603C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2407603A 2000-04-28 2001-04-27 Porphyromonas gingivalis recombinant proteins and truncations Expired - Fee Related CA2407603C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2750984A CA2750984A1 (en) 2000-04-28 2001-04-27 Porphyromonas gingivalis recombinant proteins and truncations

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ7182 2000-04-28
AUPQ7182A AUPQ718200A0 (en) 2000-04-28 2000-04-28 Porphyromonas gingivalis recombinant proteins and truncations
PCT/AU2001/000482 WO2001083530A1 (en) 2000-04-28 2001-04-27 Porphyromonas gingivalis recombinant proteins and truncations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2750984A Division CA2750984A1 (en) 2000-04-28 2001-04-27 Porphyromonas gingivalis recombinant proteins and truncations

Publications (2)

Publication Number Publication Date
CA2407603A1 CA2407603A1 (en) 2001-11-08
CA2407603C true CA2407603C (en) 2013-06-11

Family

ID=3821267

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2407603A Expired - Fee Related CA2407603C (en) 2000-04-28 2001-04-27 Porphyromonas gingivalis recombinant proteins and truncations
CA2750984A Abandoned CA2750984A1 (en) 2000-04-28 2001-04-27 Porphyromonas gingivalis recombinant proteins and truncations

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2750984A Abandoned CA2750984A1 (en) 2000-04-28 2001-04-27 Porphyromonas gingivalis recombinant proteins and truncations

Country Status (9)

Country Link
US (1) US7204991B2 (https=)
EP (1) EP1276762B1 (https=)
JP (1) JP5209166B2 (https=)
AU (1) AUPQ718200A0 (https=)
CA (2) CA2407603C (https=)
DK (1) DK1276762T3 (https=)
ES (1) ES2426034T3 (https=)
NZ (1) NZ521797A (https=)
WO (1) WO2001083530A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US7378101B2 (en) 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
US7468185B2 (en) 2001-12-21 2008-12-23 Pfizer Inc. Vaccine for periodontal disease
AU2003294350A1 (en) * 2002-11-18 2004-06-15 Boston Medical Center Corporation Immunization with porphyromonas gingivalis protects against heart disease
WO2006084129A2 (en) * 2005-02-01 2006-08-10 University Of Florida Research Foundation Genes of porphyromonas gingivalis w83 involved in invasion of human cells
WO2008000028A1 (en) 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
NZ595252A (en) * 2007-07-12 2013-11-29 Oral Health Australia Pty Ltd Biofilm treatment
AU2013203250B2 (en) * 2007-07-12 2014-11-13 Oral Health Australia Pty Ltd Immunology treatment for biofilms
CN102652831A (zh) * 2007-07-12 2012-09-05 口腔健康澳洲私人有限公司 生物膜的免疫治疗
CA2735171C (en) 2008-08-29 2023-10-03 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of p.gingivalis infection
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
WO2021203132A1 (en) * 2020-03-30 2021-10-07 Colgate-Palmolive Company Improving, maintaining, protecting and repairing tissue integrity, barrier function and immunity using a composition comprising a source of zinc ions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536497A (en) * 1992-12-21 1996-07-16 The Research Foundation Of State University Of New York Fimbrial polypeptides useful in the prevention of periodontitis
US5475097A (en) 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
US5523390A (en) 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
JP2001526035A (ja) * 1997-12-10 2001-12-18 シーエスエル、リミテッド Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
US20030083287A1 (en) * 2000-11-30 2003-05-01 Burgess Nicola A. ginS

Also Published As

Publication number Publication date
WO2001083530A1 (en) 2001-11-08
EP1276762A1 (en) 2003-01-22
JP2003531634A (ja) 2003-10-28
ES2426034T3 (es) 2013-10-18
AUPQ718200A0 (en) 2000-05-25
US20030215402A1 (en) 2003-11-20
JP5209166B2 (ja) 2013-06-12
CA2750984A1 (en) 2001-11-08
NZ521797A (en) 2005-07-29
DK1276762T3 (da) 2013-08-19
US7204991B2 (en) 2007-04-17
CA2407603A1 (en) 2001-11-08
EP1276762A4 (en) 2004-07-07
EP1276762B1 (en) 2013-05-29

Similar Documents

Publication Publication Date Title
US8784831B2 (en) P. gingivalis antigenic composition
CA2407603C (en) Porphyromonas gingivalis recombinant proteins and truncations
AU771544B2 (en) Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
EP0954529B1 (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
AU2001252042B2 (en) Porphyromonas gingivalis recombinant proteins and truncations
AU775228B2 (en) P. gingivalis antigenic composition
AU713844B2 (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
HK1149938B (en) P.gingivalis antigenic composition

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160427